In December 2019, the 2019 novel coronavirus disease (COVID-19), which has been identified to be caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China and spread across the world. Higher plasma levels of cytokines, including interleukin (IL)-6, IL-2, IL-7, IL-10, and tumor necrosis factor-α, were found in patients with COVID-19, which implies the occurrence of a cytokine storm and its association with disease severity. Extracorporeal blood purification has been proven to effectively remove the released inflammatory cytokines. In this study, we report on a patient with COVID-19 who benefited from hemoadsorption.
All Keywords
【저자키워드】 COVID-19, Treatment, 2019-nCoV, Epidemic, extracorporeal blood purification, 【초록키워드】 SARS-CoV-2, Cytokine storm, coronavirus, Cytokines, disease severity, Spread, China, 2019 novel coronavirus, plasma, Inflammatory cytokines, IL-10, disease, IL-2, IL-7, association, hemoadsorption, tumor necrosis factor-α, acute respiratory syndrome, patient with COVID-19, Occurrence, caused, released, patients with COVID-19,
【저자키워드】 COVID-19, Treatment, 2019-nCoV, Epidemic, extracorporeal blood purification, 【초록키워드】 SARS-CoV-2, Cytokine storm, coronavirus, Cytokines, disease severity, Spread, China, 2019 novel coronavirus, plasma, Inflammatory cytokines, IL-10, disease, IL-2, IL-7, association, hemoadsorption, tumor necrosis factor-α, acute respiratory syndrome, patient with COVID-19, Occurrence, caused, released, patients with COVID-19,